Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zoetis (NY: ZTS )

174.25 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
2 Healthcare Stocks That Could Make You Richer
Investors see the obvious potential in both companies. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Jim Cramer Says This E-Commerce Giant 'Is One Of The Only Ones' That 'Has Really Got The Momentum In China'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Topgolf Callaway Brands Corp. 
Via Benzinga
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years
Via Benzinga
Top 5 Health Care Stocks That May Collapse In July
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Zoetis Unusual Options Activity
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,600 Today
Via Benzinga
Looking Into Zoetis's Recent Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years
Via Benzinga
Scholastic, Matson, Digital World Acquisition And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 90 points on Friday. Here are some big stocks recording gains in today’s session. Digital World Acquisition Corp. (NASDAQ: DWAC) climbed 69%... 
Via Benzinga
2 Dividend Stocks That Doubled Their Payouts in 5 Years
There's no reason to expect these companies to stop hiking their dividend payments anytime soon. 
Via The Motley Fool
Zoetis Named One of the Best Workplaces for Innovators by Fast Company
From Zoetis Inc.
Via Business Wire
Here's How Much $1000 Invested In Zoetis 10 Years Ago Would Be Worth Today
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,000 Today
Via Benzinga
Zoetis's Return On Capital Employed Overview
Via Benzinga
Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today
Via Benzinga
Zoetis Announces Appointment of Ester Banque as President of U.S. Operations for World Leader in Animal Health
From Zoetis Inc.
Via Business Wire
Zoetis to Host Webcast and Conference Call on Second Quarter 2023 Financial Results
From Zoetis Inc.
Via Business Wire
PetVivo Sales Spryng Higher on Injectable OA Relief for Pets
Developmental biomedical device company PetVivo Holdings Inc. (NASDAQ: PETV) makes pet medical devices and therapeutics. What kind of medical devices would 
Via MarketBeat
Unmasking Q2 2023's Stars & Strugglers: Industry ETFs And Top Stock Standouts
Via Benzinga
History Suggests This S&P 500 Dividend Stock Is Perfect to Buy and Hold Forever
This highly profitable dividend growth stock could stack the odds of beating the market in your favor. 
Via The Motley Fool
Bullish or Bearish? Vetting Animal Health Care Stocks
Americans are paying more and more attention to pet health, making pet care stocks look healthy again. Here are two names worth a check up. 
Via MarketBeat
Topics ETFs
Zoetis Releases 2022 Sustainability Report to Share Progress in Building a Better Future for People, Animals and the Planet
From Zoetis Inc.
Via Business Wire
3 Ways to Play the Ongoing Demand for Farmland
If you’re considering investing in farmland, there are several ways to do so without owning the land directly. 
Via InvestorPlace
Zoetis to Participate in the Stifel 2023 Jaws and Paws Conference
From Zoetis Inc.
Via Business Wire
Zoetis Holds Investor Day and Presents Strategy to Shape Animal Health for the Next Decade
From Zoetis Inc.
Via Business Wire
Zoetis Declares New Dividend, Hinting At Undervaluation
Zoetis shareholders woke up to news of JAB's acquisition of Pumpkin, a per insurance platform where Zoetis owns a minority stake. 2023 outlooks suggest a rally 
Via MarketBeat
Zoetis Declares Third Quarter 2023 Dividend
From Zoetis Inc.
Via Business Wire
Zoetis' Osteoarthritis Med for Dogs Set to Deliver Significant Advantages In 2024, Analyst Says
Friday, the FDA approved Zoetis Inc's (NYSE: ZTS) Librela (bedinvetmab) for the control of pain associated with  
Via Benzinga
Zoetis Announces U.S. FDA Approval of Librela™ (bedinvetmab injection) to Control Osteoarthritis (OA) Pain in Dogs
From Zoetis Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.